Neuralstem Receives Patent for Neural Stem Cell Immortalization Technology

The company Neuralstem has been awarded a patent for its proprietary technology to immortalize human neural stem cells.

January 26, 2009

FDA Approves First Human Embryonic Stem Cell Trial

The biotech company Geron has received FDA approval to conduct the first human clinical trial with embryonic stem cells.

January 23, 2009

Opexa Briefs Shareholders on Corporate Update

Opexa Therapeutics holds an informative briefing on both executive and scientific company news.

January 20, 2009

Mesoblast Announces Approval of First Osteoarthritis Clinical Trial Utilizing Adult Stem Cells

The Australia-based company Mesoblast Limited announces institutional approval to begin the first human clinical trials of adult stem cell treatment for the prevention of osteoarthritis in the knee after acute traumatic injury.

January 20, 2009

Corneal Blindness in the U.K. to be Treated with Aborted Fetal Stem Cells

In a controversial ruling, the Scottish company ReNeuron has received authorization to conduct a clinical trial in which patients will be treated for corneal blindness with stem cells harvested from aborted human fetuses.

January 19, 2009

Cardiac Dysfunction Secondary to Diabetes is Treated with Adult Stem Cells

Scientists in Egypt demonstrate the ability of bone marrow stem cells to treat chronic cardiac disease that is associated with diabetes.

January 18, 2009

News and Updates

Neuralstem Receives Patent for Neural Stem Cell Immortalization Technology

FDA Approves First Human Embryonic Stem Cell Trial

Opexa Briefs Shareholders on Corporate Update

Mesoblast Announces Approval of First Osteoarthritis Clinical Trial Utilizing Adult Stem Cells

Corneal Blindness in the U.K. to be Treated with Aborted Fetal Stem Cells

Cardiac Dysfunction Secondary to Diabetes is Treated with Adult Stem Cells

Take the first step towards the healthier life you deserve.

Request Information

Conditions We Treat